Agenus’ Post

This new update to NICE guideline NG12 brings new recommendations on colorectal cancer in line with NICE’s diagnostic guidance (DG56) on ‘Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care’. https://lnkd.in/emejyjzn #clinicalguideline #cancer #healthcare

Ever wondered why we don't hear much about esophageal cancer, even though it's serious? As April marks Esophageal Cancer Awareness Month, it is the time to shed light on this often-overlooked yet critical health issue. Esophageal cancer, though relatively less common compared to other cancers, poses significant challenges due to its high mortality rate and often late-stage diagnosis. Read more: https://lnkd.in/g_7W5dS5 #esophagealcancer #esophagealcancerawareness #healthlibrary #cancer #mrmed #pharmacy #specialitymedicine

🔵 Prostate cancer is one of the most common types of cancer in men, and awareness can save lives! This month, support #ProstateCancerAwarenessMonth by sharing information with your loved ones and emphasizing the importance of early diagnosis. Raise awareness, protect, and save lives! 💙🙏 #AwarenessMonth #EarlyDiagnosisSavesLives #prostatecancer American Society of Clinical Oncology (ASCO) ESMO - European Society for Medical Oncology National Comprehensive Cancer Network® (NCCN®)

ASCO-SSO Joint Guidelines on Germline Testing in Breast Cancer (2024) ▪️All patients newly diagnosed with breast cancer who are ≤65 yr should be offered BRCA1/2 testing ▪️All patients newly diagnosed with breast cancer who are >65yr should be offered BRCA1/2 testing if they satisfy specific conditions ▪️All patients with recurrent breast cancer who are candidates for PARP inhibitor therapy should be offered BRCA1/2 testing regardless of family history ▪️All patients with a personal history of breast cancer diagnosed ≤65 years who are without active disease should be offered BRCA1/2 testing if the result will inform personal risk management or family risk assessment ▪️Testing for high penetrance genes beyond BRCA1/2, including PALB2, TP53, PTEN, STK11, and CDH1 should be offered to appropriate patients Read the entire article at https://lnkd.in/g_bZ--a7

Breast Cancer Now responds to new data showing pembrolizumab improves breast cancer outcomes regardless of age or menopausal status. Simon Vincent does this apply to men as well? #changingthefaceofbreastcancer #breastcancerinmen #1in726 Breast Cancer Now

Routine screenings are the best way to prevent colorectal cancer. Screenings are now recommended to begin at 45, not 50. On-time screening is especially important because colorectal cancer can be preventable when detected early. colonoscopytoday.com #CRCAmonth #ColorectalCancerAwarenessMonth

𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗢𝗽𝘁𝗶𝗼𝗻𝘀 If prostate cancer has been diagnosed, graded and staged, there is a lot to consider before reaching a treatment decision. Patients often feel that they must make a decision quickly. However, it is important that a patient takes time to educate himself, and reach a well-informed decision regarding his options. Read up on some of the most common treatment options here: https://loom.ly/1qUKTKg #cancertreatment #prostate #prostatecancertreatment

#Lungcancer is the most common cause of cancer death in the UK, making early diagnosis & treatment critical to improving lung cancer survival. At @GenesisCare we're providing the latest advances in treatment and delivering improved life outcomes. Read this case study of our 72-year-old patient with local recurrence of small cell lung cancer, who underwent treatment on the #MRIdian at GenesisCare five years after initial diagnosis https://bddy.me/46iYtu0